Related Experiment Videos
Genetic influences on the adjuvanticity of muramyl dipeptide in vivo
Abstract:
The possibility that the adjuvanticity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) is under genetic control in mice was examined. It was observed that MDP markedly enhances the secondary antibody response of BALB/c mice to bovine albumin but has little enhancing effect on C57BL/10Sn (B10) mice under the same conditions. This strain difference was not abolished by variations in the amount of MDP, the immunization protocol, the assay method, or the antigen used. An analysis of inbred and congenic strains showed that the responsiveness to MDP was influenced by at least two genes, one inside and one outside of the major histocompatibility complex. Mice with the C57BL background and/or the H-2b genome responded weakly to the adjuvant action of MDP, whereas those with the BALB/c or C3H background and/or H-2d or H-2k haplotypes responded more strongly. It is anticipated that the analysis of the mechanism of adjuvanticity of MDP will be facilitated by the use of mice that differ in their response to the adjuvant action of MDP.
Insights
Genetic factors influence the immune response to N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) adjuvant. Mouse strain differences in MDP adjuvanticity are linked to genes within and outside the major histocompatibility complex.
Area of Science:
- Immunology
- Genetics
- Vaccine Adjuvants
Background:
- N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) is a potent immune adjuvant.
- The genetic basis for varying responses to MDP is not fully understood.
Purpose of the Study:
- To investigate the genetic control of MDP adjuvanticity in mice.
- To identify genetic factors influencing the immune response to MDP.
Main Methods:
- Comparing the antibody response to bovine albumin in different mouse strains (BALB/c and C57BL/10Sn) after MDP administration.
- Analyzing inbred and congenic mouse strains to map genes controlling MDP responsiveness.
- Investigating the role of the major histocompatibility complex (MHC) and other genetic loci.
Main Results:
- Significant strain-dependent differences in MDP's enhancement of antibody response were observed.
- MDP adjuvanticity was influenced by at least two genes, one within and one outside the MHC.
- Mice with C57BL background and H-2b haplotype showed weak responses, while BALB/c and C3H backgrounds with H-2d or H-2k haplotypes showed stronger responses.
Conclusions:
- MDP adjuvanticity is under significant genetic control in mice.
- Genetic background, including MHC haplotypes, plays a crucial role in determining the efficacy of MDP as an adjuvant.
- Understanding these genetic influences can aid in developing more effective vaccine strategies.